NUCLEIC ACID OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV 1 AND 2) - ANVISA Registration 82568320011

Access comprehensive regulatory information for NUCLEIC ACID OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV 1 AND 2) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 82568320011 and manufactured by manufacturer not specified. The registration is held by GLOBALX TECNOLOGIA BRASIL LTDA with validity until Mar 31, 2035.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 2 companies making the same product including ABBOTT RAPID DIAGNOSTICS JENA GMBH, ROCHE MOLECULAR SYSTEMS, INC, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.